Relgin 1 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Rasagiline (1mg)
Overview Relgin 1 Tablet
Parkinson's disease is treated with Relgin 1 Tablet, a medication designed to improve motor control and reduce tremors and rigidity. This medication can be administered independently or alongside other treatments, with or without food. For consistent blood levels, adhere to a daily, fixed administration schedule. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection; avoid skipped doses and complete the entire course, even with symptom improvement. Discontinuation requires medical consultation to prevent potential complications like muscle stiffness, confusion, and high fever. Common side effects may include indigestion, joint pain, sleep disturbances, flu-like symptoms, depression, cough, swelling in the limbs (peripheral edema), and drowsiness. Dizziness may also occur; avoid activities demanding concentration until the medication's effects are known. Regular skin cancer screenings are recommended as this medication increases the risk. Report any unusual behavioral changes, including heightened libido, compulsive gambling, excessive spending, hallucinations, or mood shifts; these warrant prompt medical attention.
Primary Ingredients of Relgin 1 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Relgin 1 Tablet
Managing Parkinson's disease
Major Benefits of Relgin 1 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Relgin 1 Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Relgin 1 Tablet:
- Joint pain
- Insomnia (difficulty in sleeping)
- Indigestion
- Flu-like symptoms
- Depression
- Cough
- Peripheral edema
How to use Relgin 1 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Relgin 1 Tablet can be consumed with or without food, though consistent timing is recommended.
How Relgin 1 Tablet works:
Relgin tablets elevate brain dopamine levels, a neurotransmitter crucial for regulating motor control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Relgin 1 Tablet with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Relgin 1 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Relgin 1 Tablet. Available human data indicate potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking one Relgin tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Use of Relgin 1 Tablet in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
For individuals with liver impairment, Relgin 1 Tablet requires careful administration and may necessitate dosage modification. Physician consultation is advised. Relgin 1 Tablet is contraindicated for patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Relgin 1 Tablet :
Should you forget to take a Relgin 1 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Relgin 1 Tablet
| Label | Value |
|---|---|
| Chemical Category | Indane Byproduct |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Actions | MAO-B Inhibition |






